Mecwins
PrivateLast Round
Grant
Dec 23, 2022
Est. Valuation
$10.92M
Total Funding Raised
$7.28M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mecwins operates in Healthcare & Life Sciences and is based in Madrid. Its latest recorded funding round was a Grant round in December 2022.
Mecwins is a biotechnology company that develops and commercializes a nanotechnological platform for ultrasensitive immunoassays used in oncology, cardiovascular, and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mecwins Comparables
Compare Mecwins with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affinité Instruments | 74% | |
| Nicoya Lifesciences Inc. | 73% | |
| Quanterix Corporation | 73% |
For institutional investors. Book with your work email.
Mecwins Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 23, 2022 | ||||
| VC Round | Jun 8, 2021 | ||||
| Grant | Nov 20, 2018 | ||||
| VC Round | Oct 22, 2018 | ||||
| Series A | Jun 18, 2014 |
For institutional investors. Book with your work email.
Mecwins Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Masela Inversiones | VC Round, Series A |
| Agencia Estatal de Investigación | Grant |
| Universidad Autónoma de Madrid | Grant |
| CRB Health Tech | VC Round, Series A |
| Spanish Government (Ministry of Science) | Grant |
| CRB Bio II | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 47% MoM.
- Jun 21, 2026
Monthly visitors grew 83% MoM.
For institutional investors. Book with your work email.
Mecwins Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mecwins's valuation, stock price, and market status.
Is Mecwins a public or private company?
Mecwins is a private company.
What is the current stock price of Mecwins?
Mecwins is a private company, so its shares have no public market price. Caplight tracks Mecwins's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mecwins worth (valuation)?
Mecwins's valuation is estimated at $10.9M based on funding round data.
Can I buy Mecwins stock?
Mecwins shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mecwins's last funding round?
Mecwins's most recent funding round was Grant on December 23, 2022.
Who are the main investors in Mecwins?
Key investors in Mecwins include CRB Health Tech.
Will Mecwins IPO soon?
No public IPO plans have been announced for Mecwins.
How can I track Mecwins secondary market activity?
Caplight tracks bids, offers, and trades in Mecwins's shares on secondary markets.